India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

GlaxoSmithKline would consider buying Pfizer’s consumer health business – but only if the price is right, according to the company's chief executive. Emma Walmsley has also been busy shaking ...

Today, majors across segments including Parle Industries, Easy Trip Planners, Bajaj Consumer Care, Aditya Birla Fashion & ...

Nicotine Gums and Mints market to Witness Substantial Growth Amid Rising Demand for Smoking Cessation Products Ankush Nikam Future Market Insights, Inc. + +91 90966 84197 email us here Visit us on ...

Global Oral Care market Research Report: By Product Type, By Distribution Channel, By End User, By Formulation and By Regional ...

GSK announced several transactions involving the vesting and sale of ordinary shares under its Performance Share Plan and Deferred Investment Award Programme. The transactions involve key executives, ...

Arizona Attorney General Kris Mayes on Thursday sued drug producer GlaxoSmithKline (GSK) for harm done to asthma patients by discontinuing a long-time product.

With profit at an eight-year high, pharmaceutical May & Baker Nigeria Plc reported a 56 percent growth despite high operation ...

the Board of Directors have approved a Scheme of Amalgamation between the Company and GlaxoSmithKline Consumer Healthcare Limited (GSK CH India) to acquire the business of GSK CH India ...

News for GlaxoSmithKline Consumer Healthcare Ltd. Google.org Grants $1 Million to Karya for AI Upskilling in India Google.org awards USD 1 million to Karya, an Indian non-profit, to empower low-income ...

Shares of Eleganz Interiors opened 6% below their issue price on the NSE SME platform despite its IPO being subscribed 30 times. The funds raised will be used for debt repayment, working capital, and ...

The divestment follows an ongoing trend among pharma companies to divest their consumer health divisions, with GlaxoSmithKline due to spin out its joint venture with Pfizer into a new company ...